Company News

Suzhou Sunland Pharmatech Co., Ltd. is an innovative enterprise deeply involved in the field of cosmetic raw materials, and is committed to providing high-quality, reliable and sustainable raw material solutions for global cosmetic brands and formulators. Our product line covers many fields, such as sunscreen, skin whitening ingredients, anti-aging active substances, and tanning promoters.

Suzhou Sunland Pharmaceutical Co., Ltd. has been long focusing on the research and development and industrialization of pharmaceutical-grade active substances and effective skin care raw materials, and is committed to providing safe, effective and proven solutions for clinical treatment and high-end skin care.The company's ActiBiso™ AA 70W ( azelaic acid 70%) is gradually establishing its important position in the management of skin problems such as acne, pigment abnormalities and rosacea due to its unique preparation process and extensive clinical application value.

In the field of skin care research and development, "gentle" and "efficiency" are often regarded as difficult poles, especially for people with sensitive skin, each choice may hover between "ineffective gentleness" and "effective but accompanied by stimulation".

Consumers have long faced the contradiction of "high efficiency" and "gentleness" in the field of skin care.  ActiBiso™-GDL( Gluconolactone) ,developed by Suzhou Sunland Pharmaceutical Technology Co., Ltd., with its unique molecular structure and multiple functions, is gradually replacing traditional acids and becoming a star raw material for sensitive muscles.

Sun protection is not only a "summer necessity" in the field of modern skin care, but also the core link of skin care and anti-aging all year round. Ultraviolet radiation is an important cause of skin photoaging, pigmentation and even photosensitivity, so an efficient, safe and stable sunscreen has become the key in cosmetics research and development.

Ingredient traceability · Medical R&D background

Idebenone (IDBN) was first developed by Takeda Pharmaceutical Co., Ltd. in 1986 for the treatment of Alzheimer's disease, brain dysfunction and mental illness. Its molecular structure is derived from the modification of coenzyme Q10, and it has high lipophilicity and excellent biological activity, which can penetrate the blood-brain barrier and protect nerve cells.

In order to further deepen the international market layout and promote the global development of enterprises, Suzhou Sunland Pharmaceutical Technology Co., Ltd. will send a delegation to Vietnam from 20^th August to 30^th August, 2025 to carry out a ten-day customer visit and business exchange activities.

With the trend of functional skin care becoming "natural, efficient and safe", plant active substances have become the key words of R&D and marketing strategies of major brands.However, "nature" has never been a "safe zone" in skin care products. Without the support of standardization, mechanism research and technical application, plant ingredients can easily become empty concepts and ineffective "gimmicks".

Being well aware of the challenges and opportunities, Suzhou Sunland Pharmaceutical Technology Co., Ltd. adheres to the concept of "scientific skin care, starting from the source" and continues to make the active ingredients of plants scientific, standardized and formulated.Based on modern technology and experimental verification, we promote plant activity from traditional experience to precise skin care and reshape the new value of "plant activity".

Nowadays, as the skin care industry is constantly upgrading, consumers' attention to "safety of ingredients" and "real efficacy" has never risen as much as it is now.Suzhou Sunland Pharmaceutical Technology Co., Ltd. has been deeply involved in the research and development of functional skin care actives and sunscreen, and has always adhered to the concept of "scientific skin care, starting from the source", and is committed to provide safer and more effective raw material solutions for brand customers and end users.